|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 25.97 USD | +3.06% |
|
+2.57% | -2.77% |
| 06-30 | Jefferies Maintains Neuren Pharmaceuticals' Daybue Royalty Timeline | MT |
| 06-29 | Deutsche Bank Raises Price Target on ACADIA Pharmaceuticals to $37 From $32, Keeps Buy Rating | MT |
| Market Cap | 4.45B 3.89B 3.57B 3.33B 6.32B 423B 6.41B 42.89B 16.67B 208B 16.69B 16.33B 717B | P/E 2026 * |
67.5x | P/E 2027 * | 35.5x |
|---|---|---|---|---|---|
| Enterprise Value | 3.48B 3.04B 2.8B 2.61B 4.95B 332B 5.02B 33.59B 13.06B 163B 13.07B 12.79B 562B | EV / Sales 2026 * |
2.81x | EV / Sales 2027 * | 2.35x |
| Free-Float |
99.68% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: ACADIA Pharmaceuticals Inc.
| 1 day | +3.06% | ||
| 1 week | +2.57% | ||
| Current month | +2.65% | ||
| 1 month | +19.57% | ||
| 3 months | +16.98% | ||
| 6 months | -1.22% | ||
| Current year | -2.77% |
| 1 week | 24.94 |  | 26.23 |
| 1 month | 20.84 | | 27.31 |
| Current year | 19.89 | | 27.81 |
| 1 year | 19.69 | | 28.35 |
| 3 years | 13.4 | | 33.99 |
| 5 years | 12.24 | | 33.99 |
| 10 years | 12.24 | | 58.72 |
| Manager | Title | Age | Since |
|---|---|---|---|
Catherine Adams
CEO | Chief Executive Officer | 55 | 20/09/2024 |
Mark Schneyer
DFI | Director of Finance/CFO | 52 | 10/09/2021 |
Scott Cenci
CTO | Chief Tech/Sci/R&D Officer | - | 04/08/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Laura Brege
BRD | Director/Board Member | 68 | 01/05/2008 |
Stephen Biggar
CHM | Chairman | 55 | 10/06/2016 |
Edmund Harrigan
BRD | Director/Board Member | 73 | 25/11/2015 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 06-26 | Sell | Controller/Auditor | -11,421 | 0.0067% | ||
| 05-29 | Fiscal year | Director | 41,529 | 0.0243% | ||
| 05-29 | Other | Director | 0 | 0% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +3.06% | +2.57% | +23.96% | +8.21% | 4.45B | |
| +1.70% | +7.41% | +2.50% | +8.22% | 49.92B | |
| +0.92% | +3.93% | +399.71% | +605.33% | 40.23B | |
| +1.89% | +8.32% | +26.06% | -6.35% | 34.55B | |
| +2.38% | +6.35% | +21.25% | +64.58% | 33.09B | |
| +3.96% | +10.67% | +8.30% | +40.44% | 27.51B | |
| +2.51% | +5.27% | - | - | 17.05B | |
| +2.58% | +5.79% | +73.44% | +133.27% | 15.92B | |
| +0.32% | +0.58% | +14.00% | +19.59% | 13.86B | |
| +3.30% | +0.76% | +90.23% | +99.12% | 13.52B | |
| Average | +2.26% | +6.19% | +73.27% | +108.05% | 25.01B | |
| Weighted average by Cap. | +2.08% | +6.59% | +88.94% | +135.43% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 1.24B 1.09B 997M 929M 1.76B 118B 1.79B 11.97B 4.65B 58.09B 4.66B 4.56B 200B | 1.39B 1.22B 1.12B 1.04B 1.98B 133B 2.01B 13.45B 5.23B 65.26B 5.23B 5.12B 225B |
| Net income | 66M 57.69M 53.02M 49.42M 93.74M 6.28B 95.16M 637M 247M 3.09B 248M 242M 10.64B | 133M 116M 107M 99.65M 189M 12.67B 192M 1.28B 499M 6.23B 499M 489M 21.46B |
| Net Debt | -965M -843M -775M -722M -1.37B -91.84B -1.39B -9.3B -3.62B -45.14B -3.62B -3.54B -156B | -1.18B -1.03B -946M -881M -1.67B -112B -1.7B -11.35B -4.41B -55.09B -4.42B -4.32B -190B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 02/07/26 | $25.97 | +3.06% | 1,586,395 |
| 01/07/26 | $25.20 | -0.40% | 1,417,658 |
| 30/06/26 | $25.30 | +0.40% | 1,721,284 |
| 29/06/26 | $25.20 | -0.47% | 2,090,012 |
| 26/06/26 | $25.32 | +6.75% | 7,370,513 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ACAD Stock
Select your edition
All financial news and data tailored to specific country editions
